BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 29, 2021-- Labcorp (NYSE: LH), a leading life sciences company, today announced results for the first quarter ended March 31, 2021 and raised 2021 guidance.
BURLINGTON, N.C., April 22, 2021 — Labcorp® (NYSE: LH), a leading global life sciences company, today announced the opening of an automated clinical trial kit production line in Mechelen, Belgium, which doubles the automated production capacity of the company’s industry-leading central laboratory services unit. The central laboratory services unit is part of Labcorp’s Drug Development business, also known as Covance by Labcorp.
Labcorp Opens Automated Clinical Trial Kit Production Line at New European Operations Center
In Pursuit of Answers
We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—because we know that knowledge has the potential to make life better for all.
We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—because we know that knowledge has the potential to make life better for all.
BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 20, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of the Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit for small businesses, an initiative aimed at providing fast, convenient, and reliable testing for companies with as many as 120 employees. Labcorp Employer Services currently provides COVID-19 testing and vaccination services for larger organizations and communities.